Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

ClinicalTrials.gov ID: NCT02611804

Public ClinicalTrials.gov record NCT02611804. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 10:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy and safety profiles of Teva's Diclofenac Sodium Gel, 5% (test product) to Solaraze® (diclofenac sodium) Gel, 3% (reference product) to demonstrate the clinical equivalence and to show that the efficacy of the 2 active formulations is superior to that of vehicle in treating subjects with actinic keratosis (AK) on the face or bald scalp.

Study identification

NCT ID
NCT02611804
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Teva Pharmaceuticals USA
Industry
Enrollment
492 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2015 (Type not available)
Primary completion
Aug 2016 (Actual)
Completion
Aug 2016 (Actual)
Last update posted
May 5, 2017

2015 – 2016

United States locations

U.S. sites
30
U.S. states
15
U.S. cities
26
Facility City State ZIP Site status
Agave Clinical Research Mesa Arizona 85202 —
Radiant Research, Inc. Tucson Arizona 85712 —
Center for Dermatology Clinical Research, Inc. Fremont California 94538 —
Medical Center for Clinical Research San Diego California 92108 —
TCR Medical Corporation San Diego California 92123 —
Clinical Science Institute Santa Monica California 90404 —
Horizons Clinical Research Center Denver Colorado 80220 —
Olympian Clinical Research Clearwater Florida 33757 —
Tampa Bay Medical Research Clearwater Florida 33761 —
Renstar Medical Research Ocala Florida 34471 —
DS Research Louisville Kentucky 40202 —
Dermatology Consulting Services High Point North Carolina 27262 —
DermOne of North Carolina Wilmington North Carolina 28401 —
PMG Research of Winston-Salem Winston-Salem North Carolina 27103 —
Radiant Research Cincinnati Ohio 45249 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Omega Medical Research Warwick Rhode Island 02886 —
Radiant Research Anderson South Carolina 29621 —
Greenville Dermatology Greenville South Carolina 29607 —
Dermatology Associates of Knoxville Knoxville Tennessee 37917 —
The Skin Wellness Center Knoxville Tennessee 37922 —
Tennessee Clinical Research Center Nashville Tennessee 37215 —
DermResearch, Inc. Austin Texas 78759 —
The Center for Skin Research Houston Texas 77056 —
ACRC Trials Plano Texas 75024 —
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229 —
Stephen Miller, M.D. San Antonio Texas 78249 —
Dermatology Research Center Salt Lake City Utah 84117 —
The Education and Research Foundation Lynchburg Virginia 24501 —
Premier Clinical Research Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02611804, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2017 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02611804 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →